Andrew Carr

deltaDOT Ltd. develops and commercializes technologies for the separation and analysis of biomolecules. It offers High Performance Capillary Electrophoresis and Conventional Capillary Electrophoresis, and analytical services and contract research. The company was founded by Stuart Hassard and John Hassard in 2000 and is headquartered in London, the United Kingdom.

Akubio Ltd. develops acoustic biosensor instruments. Its products are used in protein research and drug development. The company's technology based on quartz resonators delivers molecular identification and measurement of interactions in complex samples. Akubio was founded by Matthew A. Cooper in August 2001 and is headquartered in Cambridge, UK

Part of Danaher Corp., Global Life Sciences Solutions USA LLC is a company that manufactures therapeutics. The company is based in Marlborough, MA.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

BAC BV discovers, develops and manufactures affinity ligands and affinity purification products for the biopharmaceutical market. Its CaptureSelect products are used for drug discovery up to manufacturing of biopharmaceuticals and are based on a proprietary platform technology, integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies derived from Camelids. The company was founded in 1995 and is headquartered in Amsterdam, the Netherlands.

Part of Thermo Fisher Scientific, Inc., Thermo Fisher Scientific Oy is a Finnish company that manufactures and supplies medical and dental instruments. The company is based in Vanda, Finland. The CEO of the company is Timo Tapio Hildén.

Cytox Ltd. develops products and services for neurodegenerative disorders. It develops cellular and genetic assays for Alzheimer’s disease diagnosis. The firm offers biomarker services to pharmaceutical companies conducting clinical trials with drugs for the treatment of AD and mild cognitive impairment; and drug-screening services. The company was founded by Zsuzsanna Nagy, Margaret Esiri, Roy Bicknell and James S. Chadwick in 2004 and is headquartered in Oxford, the United Kingdom.